SNY

46 Actions To Take Now That The Dollar Has Cracked

The U.S. dollar has cracked, with the currency falling to a seven-month low against the euro and Yen. Here's what you should do now in your portfolio More 

FDA Reviewers: Nasacort Allergy Spray Can Go OTC

Sanofi's Nasacort anti-asthma treatment has been declare safe enough for non-prescription sales by U.S. Food and Drug Administration reviewers. More 

10 Hot New Products With Staying Power

Nielsen has revealed the best-selling new products of the last two years, and here's a list of the top ten. More 

Trade of the Day: Novo Nordisk (NVO)

Obesity-related disease is spreading across the world -- and traders should consider the pharmaceutical companies that will grow because of that trend. More 

74 Actions to Take For the Earnings Shakeout

Earnings season has kicked into high gear, and here is how to stay ahead of these 74 stocks More 

5 Large-Cap Growth Stocks That Aren’t Done

Most people associate small-cap stocks with growth, not large caps -- but these high-worth companies have pretty impressive earnings upside themselves. More 

It’s Hard to Win the Pharma News Game

Big news for three cancer-treatment drugs had virtually zero effect on the stocks. Here's why investors shouldn't have been surprised, and what they can learn. More